
USD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$127.94B
Market Cap
27.33
P/E Ratio
3.65
EPS
$106.33
52 Week High
$76.99
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $22B |
| Total Revenue | $34B |
| Cost Of Revenue | $12B |
| Costof Goods And Services Sold | $12B |
| Operating Income | $6B |
| Selling General And Administrative | $11B |
| Research And Development | $2.7B |
| Operating Expenses | $16B |
| Investment Income Net | - |
| Net Interest Income | -$729M |
| Interest Income | $612M |
| Interest Expense | $729M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $2.9B |
| Income Before Tax | $5.6B |
| Income Tax Expense | $936M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $4.7B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $6.4B |
| Ebitda | $9.2B |
| Net Income | $4.7B |
| Field | Value (USD) |
|---|---|
| Gross Profit | $22B |
| Total Revenue | $34B |
| Cost Of Revenue | $12B |
| Costof Goods And Services Sold | $12B |
| Operating Income | $6B |
| Selling General And Administrative | $11B |
| Research And Development | $2.7B |
| Operating Expenses | $16B |
| Investment Income Net | - |
| Net Interest Income | -$729M |
| Interest Income | $612M |
| Interest Expense | $729M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $2.9B |
| Income Before Tax | $5.6B |
| Income Tax Expense | $936M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $4.7B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $6.4B |
| Ebitda | $9.2B |
| Net Income | $4.7B |
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-12-26 |
| Declaration Date | 2025-12-04 |
| Record Date | 2025-12-26 |
| Payment Date | 2026-01-16 |
| Amount | 0.71 |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Medtronic plc is a leading global medical technology company headquartered in Fridley, Minnesota, specializing in the development and commercialization of advanced medical devices and therapies across key sectors such as cardiovascular, diabetes management, and neuromodulation. With a strong emphasis on innovation, Medtronic invests significantly in research and development to create cutting-edge healthcare solutions that enhance patient outcomes and quality of life. The company's commitment to sustainability and value-driven healthcare further strengthens its position as a pivotal player in the evolving medical device industry, ensuring it remains well-equipped to address the complex challenges of modern healthcare.